US Pharma MarketingAmgen, academic centers weigh new FDA pilot to speed early drug trials
To better combat China and Australia's dominance in expediting early-phase trials, the FDA and stakeholders are ironing out the details of a pilot program to accelerate first-in-human trials. Amgen, Memorial Sloan Kettering Cancer Center, the ...
To better combat China and Australia's dominance in expediting early-phase trials, the FDA and stakeholders are ironing out the details of a pilot program to accelerate first-in-human trials.
Amgen, Memorial Sloan Kettering Cancer Center, the ...
Source: Endpoints News